Michael Ryskin
Stock Analyst at B of A Securities
(1.53)
# 3,488
Out of 5,090 analysts
38
Total ratings
54.17%
Success rate
-0.51%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVTY Revvity | Maintains: Buy | $110 → $99 | $100.79 | -1.78% | 1 | Sep 22, 2025 | |
| TEM Tempus AI | Maintains: Neutral | $68 → $70 | $76.66 | -8.69% | 6 | Jun 25, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Neutral | $535 → $475 | $714.10 | -33.48% | 3 | Apr 21, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Buy | $9 → $8 | $3.70 | +116.22% | 3 | Mar 3, 2025 | |
| ALGN Align Technology | Maintains: Underperform | $200 → $206 | $157.21 | +31.03% | 6 | Dec 13, 2024 | |
| GH Guardant Health | Maintains: Buy | $28 → $40 | $102.02 | -60.79% | 1 | Jul 18, 2024 | |
| ALIT Alight | Maintains: Buy | $10 → $9.5 | $2.04 | +365.69% | 1 | Jun 25, 2024 | |
| CERT Certara | Maintains: Buy | $27 → $24 | $9.22 | +160.30% | 2 | Aug 15, 2023 | |
| AVTR Avantor | Maintains: Buy | $27 → $24 | $10.93 | +119.58% | 2 | Jul 31, 2023 | |
| ZTS Zoetis | Maintains: Buy | $225 → $180 | $118.65 | +51.71% | 7 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.71 | - | 2 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $80 → $52 | $17.64 | +194.78% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $17 → $10 | $3.58 | +179.33% | 2 | Nov 10, 2021 |
Revvity
Sep 22, 2025
Maintains: Buy
Price Target: $110 → $99
Current: $100.79
Upside: -1.78%
Tempus AI
Jun 25, 2025
Maintains: Neutral
Price Target: $68 → $70
Current: $76.66
Upside: -8.69%
IDEXX Laboratories
Apr 21, 2025
Maintains: Neutral
Price Target: $535 → $475
Current: $714.10
Upside: -33.48%
Maravai LifeSciences Holdings
Mar 3, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $3.70
Upside: +116.22%
Align Technology
Dec 13, 2024
Maintains: Underperform
Price Target: $200 → $206
Current: $157.21
Upside: +31.03%
Guardant Health
Jul 18, 2024
Maintains: Buy
Price Target: $28 → $40
Current: $102.02
Upside: -60.79%
Alight
Jun 25, 2024
Maintains: Buy
Price Target: $10 → $9.5
Current: $2.04
Upside: +365.69%
Certara
Aug 15, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $9.22
Upside: +160.30%
Avantor
Jul 31, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $10.93
Upside: +119.58%
Zoetis
Nov 4, 2022
Maintains: Buy
Price Target: $225 → $180
Current: $118.65
Upside: +51.71%
Apr 18, 2022
Downgrades: Neutral
Price Target: n/a
Current: $4.71
Upside: -
Nov 11, 2021
Downgrades: Neutral
Price Target: $80 → $52
Current: $17.64
Upside: +194.78%
Nov 10, 2021
Downgrades: Underperform
Price Target: $17 → $10
Current: $3.58
Upside: +179.33%